15930421

Source:http://linkedlifedata.com/resource/pubmed/id/15930421

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0006142, umls-concept:C0246415, umls-concept:C0746319, umls-concept:C1522673
pubmed:issue	22
pubmed:dateCreated	2005-6-2
pubmed:abstractText	We compared docetaxel plus doxorubicin and cyclophosphamide (TAC) with fluorouracil plus doxorubicin and cyclophosphamide (FAC) as adjuvant chemotherapy for operable node-positive breast cancer.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/15930421-15930427, http://linkedlifedata.com/resource/pubmed/commentcorrection/15930421-16135845, http://linkedlifedata.com/resource/pubmed/commentcorrection/15930421-16136712, http://linkedlifedata.com/resource/pubmed/commentcorrection/15930421-16157623
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0255562
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Phytogenic, http://linkedlifedata.com/resource/pubmed/chemical/Cyclophosphamide, http://linkedlifedata.com/resource/pubmed/chemical/Doxorubicin, http://linkedlifedata.com/resource/pubmed/chemical/Fluorouracil, http://linkedlifedata.com/resource/pubmed/chemical/Taxoids, http://linkedlifedata.com/resource/pubmed/chemical/docetaxel
pubmed:status	MEDLINE
pubmed:month	Jun
pubmed:issn	1533-4406
pubmed:author	pubmed-author:Al-TweigeriTaherT, pubmed-author:BlitzSandraS, pubmed-author:Breast Cancer International Research Group 001 Investigators, pubmed-author:ChapLinneaL, pubmed-author:ColemanRobertR, pubmed-author:ColwellBruceB, pubmed-author:FornanderTommyT, pubmed-author:GuevinRaymondR, pubmed-author:HainsworthJohnJ, pubmed-author:HowellAnthonyA, pubmed-author:HughJudithJ, pubmed-author:JacobsPhilipP, pubmed-author:Jean-PaulGuastallaG, pubmed-author:JuhosEvaE, pubmed-author:LoretCamilleC, pubmed-author:MackeyJohnJ, pubmed-author:MartinMiguelM, pubmed-author:ModianoManuelM, pubmed-author:MurawskyMichaelM, pubmed-author:PawlickiMarekM, pubmed-author:PienkowskiTadeuszT, pubmed-author:PinterTamasT, pubmed-author:PradyCatherineC, pubmed-author:ProvencherLouiseL, pubmed-author:RivaAlessandroA, pubmed-author:Rodriguez-LescureAlvaroA, pubmed-author:RupinMatthieuM, pubmed-author:TangShou CSC, pubmed-author:TomiakEvaE, pubmed-author:VinholesJefersonJ, pubmed-author:VogelCharlesC, pubmed-author:WaldeDavidD, pubmed-author:WeaverCharlesC
pubmed:copyrightInfo	Copyright 2005 Massachusetts Medical Society.
pubmed:issnType	Electronic
pubmed:day	2
pubmed:volume	352
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	2302-13
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:15930421-Adult, pubmed-meshheading:15930421-Aged, pubmed-meshheading:15930421-Antineoplastic Agents, Phytogenic, pubmed-meshheading:15930421-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:15930421-Breast Neoplasms, pubmed-meshheading:15930421-Chemotherapy, Adjuvant, pubmed-meshheading:15930421-Cyclophosphamide, pubmed-meshheading:15930421-Disease-Free Survival, pubmed-meshheading:15930421-Doxorubicin, pubmed-meshheading:15930421-Female, pubmed-meshheading:15930421-Fluorouracil, pubmed-meshheading:15930421-Follow-Up Studies, pubmed-meshheading:15930421-Humans, pubmed-meshheading:15930421-Lymphatic Metastasis, pubmed-meshheading:15930421-Middle Aged, pubmed-meshheading:15930421-Quality of Life, pubmed-meshheading:15930421-Survival Analysis, pubmed-meshheading:15930421-Taxoids
pubmed:year	2005
pubmed:articleTitle	Adjuvant docetaxel for node-positive breast cancer.
pubmed:affiliation	Hospital Universitario San Carlos, Madrid, Spain. mmartin@geicam.org
pubmed:publicationType	Journal Article, Clinical Trial, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study, Clinical Trial, Phase III